PEAK6 Investments’s Axonics, Inc. Common Stock AXNX Stock Holding History

PEAK6 Investments’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-100	Closed	-$6.9K	–	4491
2024 Q1	$6.9K	Sell	100 -2,500	-96%	-$169K	﹤0.01%	3763
2023 Q4	$162K	Hold	2,600	–	–	﹤0.01%	3357
2023 Q3	$146K	Buy	+2,600	New	+$146K	﹤0.01%	3230
2022 Q2	–	Sell	-10,000	Closed	-$626K	–	6636
2022 Q1	$626K	Sell	10,000 -7,600	-43%	-$410K	﹤0.01%	2924
2021 Q4	$986K	Sell	17,600 -4,200	-19%	-$257K	﹤0.01%	2574
2021 Q3	$1.42M	Buy	21,800 +10,700	+96%	+$730K	﹤0.01%	2291
2021 Q2	$704K	Buy	11,100 +4,500	+68%	+$266K	﹤0.01%	2928
2021 Q1	$395K	Buy	+6,600	New	+$359K	﹤0.01%	3409

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PEAK6 Investments's AXNX Position: Q2 2022 in Review

PEAK6 Investments sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2022, closing a stake of 3,541 shares — an estimated $222K sold.

PEAK6 Investments first reported a position in AXNX in Q2 2020 and held it in 6 quarters. The position peaked at $1.29M in Q4 2020. 196 funds tracked by Wall St. Rank hold AXNX as of Q2 2022.

PEAK6 Investments reported no remaining Axonics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
PEAK6 Investments sold 3,541 Axonics, Inc. Common Stock shares in Q2 2022, an estimated $222K.
PEAK6 Investments first reported a position in Axonics, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
PEAK6 Investments's Axonics, Inc. Common Stock position peaked at $1.29M in Q4 2020.
196 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2022.

Based on PEAK6 Investments's 13F filing for Q2 2022, filed 12 Aug 2022.